David Sinclair@davidasinclair• 9 months ago

GLP1 receptor agonists are looking like longevity drugs. A new study reports that drug-induced improvements in bone mass are mediated by the NAD-dependent SIRT1 enzyme. If so, could NAD boosters work with GLP-1 drugs? Some thoughts...🧵 https://t.co/6LXgnwHTVy